ADJUVANT Bisphosphonates in Early Breast Cancer – Pharmacist Survey

We would be really grateful if you could spend 1 min of your time to complete this quick survey for the use of ADJUVANT Bisphosphonates in Early Breast Cancer.

Please click on the following link to complete the survey: https://www.surveymonkey.co.uk/r/N7BX5BR

Adjuvant Bisphosphonates are now standard of care in Early Breast Cancer and our aim, through this pharmacists’ survey, is to confirm their use in the UK.

Latest News

By BOPA Committee on behalf of UK SACT board on 23rd May 2025

UK SACT Board publication: Guidance on the contents of a SACT protocol

  Dear Colleague,   Please find a link to the updated publication, “Guidance for the Content of SACT Protocol,” available here: https://www.uksactboard.org/publications.   This document has been developed to support…

Read article
By BOPA Executive Committee on 21st May 2025

Vision and Common Purpose for UK Pharmacy Professional Leadership – UKPPL Board and BOPA

BOPA is an Ex-Officio Member (Specialist Pharmacy Group) of the UKPPL Board with our Chair, Joseph Williams, representing BOPA members and all Cancer Pharmacy Professionals.  Through the Board’s work, closer…

Read article
By BOPA Executive Committee on 14th May 2025

BOPA Fellowship Nominations are NOW OPEN!

We are pleased to announce that BOPA Fellowship Nominations have now opened for 2025.  There is a clear nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Committee on 13th May 2025

#BOPA2025 at ICC Belfast – Draft Agenda now available

The 28th British Oncology Pharmacy Association (BOPA) Annual Conference, 3-5 October 2025, ICC Belfast The Draft Agenda is available to view here: https://www.bopa.org.uk/resources/the-28th-bopa-annual-conference-2025-draft-agenda/ The conference will include an exciting variety…

Read article